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Abstract
Background: Many newly screened people living with HIV (PLHIV) in Sub-Saharan Africa do not understand the
importance of regular pre-antiretroviral (ARV) care because most of them have been counseled by staff who lack
basic counseling skills. This results in low uptake of pre-ARV care and late treatment initiation in resource-poor
settings. The effect of providing post-test counseling by staff equipped with basic counseling skills, combined with
home visits by community support agents on uptake of pre-ARV care for newly diagnosed PLHIV was evaluated
through a randomized intervention trial in Uganda.
Methods: An intervention trial was performed consisting of post-test counseling by trained counselors, combined
with monthly home visits by community support agents for continued counseling to newly screened PLHIV in
Iganga district, Uganda between July 2009 and June 2010, Participants (N = 400) from three public recruitment
centres were randomized to receive either the intervention, or the standard care (the existing post-test counseling
by ARV clinic staff who lack basic training in counseling skills), the control arm. The outcome measure was the
proportion of newly screened and counseled PLHIV in either arm who had been to their nearest health center for
clinical check-up in the subsequent three months +2 months. Treatment was randomly assigned using computer-
generated random numbers. The statistical significance of differences between the two study arms was assessed
using chi-square and t-tests for categorical and quantitative data respectively. Risk ratios and 95% confidence
intervals were used to assess the effect of the intervention.
Results: Participants in the intervention arm were 80% more likely to accept (take up) pre-ARV care compared to
those in the control arm (RR 1.8, 95% CI 1.4-2.1). No adverse events were reported.
Conclusions: Provision of post-test counseling by staff trained in basic counseling skills, combined with home
visits by community support agents had a significant effect on uptake of pre-ARV care and appears to be a cost-
effective way to increase the prerequisites for timely ARV initiation.
Trial registration: The trial was registered by Current Controlled Trials Ltd C/OBioMed Central Ltd as
ISRCTN94133652 and received financial support from Sida and logistical support from the European Commission.
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Post-test counseling is a vital tool for uptake and adher-
ence to regular pre-antiretroviral (pre-ARV) care and
timely entry into antiretroviral care (ART) for people
living with HIV (PLHIV) [1-4]. The counseling also
helps PLHIV fight stigma, disclose their HIV status and
adhere to ART when initiated [2,5-8]. The WHO pro-
vides post-test counseling guidelines for PLHIV [4], but
in many low-income settings these guidelines are not
followed, partly because the staff are overloaded and/or
have not been trained in basic counseling skills [9].
Consequently, many newly screened PLHIV in such set-
tings do not appreciate the importance of regular pre-
ARV care resulting into low uptake of pre-ARV or high
loss to follow up during pre-ARV care [10-16].
In Iganga district, Uganda, over 90% of the 1400 newly
screened PLHIV between 2004 and 2007 never attended
pre-ARV care or were lost to follow-up during pre-ARV
care. In Iganga district, as commonly encountered
throughout Sub-Saharan Africa, post-test counseling at
the ART clinic is conducted by staff who lack basic
training in counseling skills. Staff are often overloaded
as they also have been assigned work in other depart-
ments in addition to their tasks in the ART clinic (task
piling). Most normally neither have access to, nor follow
the WHO counseling guidelines when offering HIV
counseling services (District health office 2009-
unpublished).
In December 2008, our research team conducted a
qualitative study to explore reasons for failure to take
up or loss to follow up of PLHIV during pre-ARV care
in eastern Uganda interviewing PLHIV, half of whom
had dropped out of pre-ARV care, and their next of kin.
The recurrent theme for failure to take up or adherence
to regular pre-ARV care was inadequate post-test coun-
seling for PLHIV on when and why they should return
for care [17].
A randomized controlled trial was thus conducted to
assess whether a low-cost intervention through provid-
ing post-test counseling by staff with training in basic
counseling skills, combined with home visits by commu-
nity support agents for extended counseling, could
improve uptake of pre-ARV care among newly diag-
nosed PLHIV, minimize loss to follow-up during pre-
ARV care, and, subsequently enhance timely initiation
of ART in this resource-poor district in eastern Uganda.
Methods
Trial design
This was a parallel group balanced (1:1) client rando-
mized and single blind superiority controlled trial con-
ducted in three health facilities in Iganga district,
eastern Uganda.
Eligibility criteria
Eligible participants consisted of all newly screened
HIV-positive adult clients (>18 yrs) at the three recruit-
ment centres at the start of the study, who were of
sound mental status, and who were not under the pre-
vention of mother to child transmission (PMTCT) pro-
gram or bound to leave the district during the period of
follow-up.
Study setting and location
The study was conducted in Iganga district located
approximately 115 km east of the capital Kampala
between July 2009 and June 2010. The three recruitment
centres included Iganga district hospital and two Health
Centre (HC) IVs of Kiyunga and Busesa Health Sub Dis-
tricts (HSD). These centres were purposively selected
because they had a constant supply of test kits and active
pre-ARV clinics. The hospital serves a catchment area of
approximately 600,000 people while each of the two HC
IVs serves a population of approximately 100,000 people.
There are 101 health units in the district, 70 of which are
HC II, 27 HC III, 3 HC IV and one general hospital.
Ideally all health units should offer voluntary counsel-
ling and testing (VCT) and other aspects of pre-ARV
care, but currently only the HC at level IV and the hos-
pital actually offer these services. The lower level units
(HC II and III) normally run out of stock of HIV test
kits and cotrimoxazole (District health office 2009-
unpublished). The district has over 200 private drug
shops/private clinics scattered in the main Iganga town
and many others in small towns in the district. These
drug shops/private clinics are not officially accredited to
offer pre-ARV care but often sell cotrimoxazole which is
one important component of pre-ARV care to PLHIV
(District health office 2009-unpublished).
Over 90% of the residents in the district are rural sub-
sistence farmers and the majority belong to the Basoga
tribe (District health office 2009-unpublished).
Approximately 40,000 (6.7% of the district adult popu-
lation) are estimated to be living with HIV with over
6,000 of PLHIV presumed to be eligible for ART
(MOH, 2006, UNAIDS/WHO, 2007). Currently 3500
PLHIV regularly attend pre-ARV care and approxi-
mately a 1000 are on ART in the district [18,19].
VCT is conducted either on client’s demand or occa-
sionally when demanded by the clinicians on suspicion
of HIV infection or AIDS. The post-test counseling is
however mostly conducted by nurses or nursing assis-
tants attached to the ART clinic.
Description of the intervention
The design involved following newly screened PLHIV
after post-test counseling for uptake of pre-ARV care at
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to their homes. Following a positive HIV test, the parti-
cipants were randomized into one of two arms: the con-
trol arm and the intervention arm. The participants in
the control arm received standard care including post-
test counseling by staff not trained in basic counseling
skills at any of the three recruitment centres. Standard
counseling included assignment of an identification
number, declaration of the results, provision of cotri-
moxazole prophylaxis and advice to the client to go for
pre-ARV care at the nearest HC every three months.
The participants in the intervention arm received
another form of counseling and follow-up. The specia-
lized counseling was conducted by six health workers
who had been trained on basic counseling skills for
three days at a direct financial cost of twenty (20) USD
per staff. During the training, it was emphasized that
those who had been trained should not share their new
skills with the staff selected for the control arm. The
counseling offered in the intervention arm similarly
involved allocation of an identification number, declara-
tion of the results to the client and cotrimoxazole pro-
phylaxis. In addition, the counsellor encouraged self-
disclosure of HIV status to the participant’s immediate
family, promoted positive living with HIV, HIV preven-
tion and emphasized the importance of going for pre-
ARV care at the nearest HC every three months. As
part of the intervention, these participants were also
attached to an HIV/AIDS community support agent
close to their area of residence who visited them
monthly at their homes for a two hour counseling ses-
sion and reminded them to go to the nearest health
centre for quarterly pre-ARV care. HIV/AIDS commu-
nity support agents are influential volunteers in the
community or ART expert clients who have been sensi-
tized and assigned the role of counseling and encoura-
ging PLHIV to seek care and subsequently link them to
the service providers. The community support agents
had been trained and registered by the district in pre-
vious five years but they also received a one-day orienta-
tion about the present study.
Outcome measures
The outcome measure was the proportion of newly
detected and counseled PLHIV in either arm who had
been to their nearest HC for clinical check-up in the sub-
sequent three months after enrollment. An allowance of
extra two months to return for check-up was considered
for every participant to cater for any inevitable circum-
stances that would prohibit the participant from going
for check-up. The participants in both arms were fol-
lowed up and considered to have taken up (accepted) or
not taken up (not accepted) pre-ARV care according to
the following definition: those who went for clinical
check-up at the nearest HC at least once in the subse-
quent three months (+ 2 months, see above) were consid-
ered to have taken up pre-ARV care, while those who
missed their scheduled appointment to the pre-ARV
clinic in the subsequent three months (+2 months) were
considered not to have taken up pre-ARV care (Figure 1).
Independent variables
Information was collected on the following important
factors or potential confounders to pre-ARV uptake;
socio-demographic characteristics such as age, sex, edu-
cation, religion, marital status, marriage status, occupa-
tion and number of people in the house-hold.
Information was also collected on knowledge of HIV
transmission, prevention, pre-ARV care and its impor-
tance and stigma. For participants who went to their
nearest HC for pre-ARV care after 3 months (+ 2
months) information on reasons for going for care, dis-
closure and motivational factors for disclosure, any side
effects of cotrimoxazole, constraints to pre-ARV care
seeking, condom use and number of sexual partners was
also collected.
Data collection techniques
The baseline data for every enrolled participant was col-
lected through face-to face interviews following a short
structured questionnaire by a trained research assistant
at each of the respective three recruitment centres.
Every enrolled participant was then scheduled to seek
pre-ARV care after 3 months at their nearest HC jointly
agreed on by the counselling staff and the participant. A
research assistant identified at each of these agreed
health centres collected data from the study participants
at the end of the follow-up period.
All the counsellors and corresponding research assis-
tants were trained for three days on the study aim,
design and tools. The study tools were pre-tested using
a pilot study at another HC IV offering ART in the
area. Experiences from the pilot study were discussed at
an extra session separately for each arm. Necessary
changes were then made to the tools and the research
assistants were given additional guidance. Throughout
the study period, random validity checks at the HC were
conducted by the first and second author (LM and TN)
to ensure compliance, and also to collect the completed
corresponding questionnaires. The completed question-
naires were then checked for consistency, range of
values and completeness.
Sample size
The sample size was calculated using a formula sug-
gested by both Altman and Bland [20,21]. At a power of
80%, estimated pre-ARV uptake of 50% for the control
arm, a target to detect a difference of absolute 14% in
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mum of 193 participants (rounded up to 200) per arm
was found adequate. The proportion of newly screened
PLHIV normally differs between the different study cen-
tres. I It is twice as high at Iganga hospital compared to
Busesa and Kiyunga respectively. Based on these propor-
tions, 50% (200 participants 100 in each arm) were
enrolled at Iganga hospital and 25% (100 participants 50
in each arm) were recruited at each of the other two
recruitment centres (District health office 2009-
unpublished).
Randomization and masking
In all the study centres, participants were randomly
assigned to receive the standard post-test counseling or
extended counseling. Treatment assignment was ran-
domly generated in blocks of four based on computer
generated random number sequences provided by one
of the statisticians in the study team (DK) who had no
contact with the study participants. Assignment
sequences were placed in opaque sealed envelopes and
appropriate numbers sent to each of the study centres.
At each centre, participant enrollment was done by an
assigned laboratory technician who carried out the HIV
testing. After a client had tested HIV positive, the tech-
nician at each centre asked the eligible client to pick
and open an envelope from a batch of four for assign-
ment to the appropriate arm. At each centre this
procedure continued until the required allocated num-
bers per arm had been realized. Given the nature of the
intervention, it was hard to mask the staff in the differ-
ent arms as to which arm they themselves belonged.
None of the study subjects, however, was informed of
the details of the arm to which they had been assigned.
To limit contamination between and among the
research assistants and the participants, however, each
arm at every centre was put in different rooms at least
50 metres apart. The staff members were also instructed
not to share the nature and content of counselling they
offered to the participants.
Data management and analysis
All the completed and edited questionnaires were dou-
ble-entered and cleaned using using Epi-Info version
2000. The cleaned data were then exported to STATA8
(STATA Corporation, college station TX USA) where
analysis was carried out in three stages.
Stage 1 involved a description of baseline characteris-
tics of the participants in the two arms to find out how
comparable they were with respect to potential confoun-
ders such as age, education, and marital status. Chi-
square and the t-test were used to test for any signifi-
cant differences between the two arms for categorical
and quantitative data respectively.
Stage 2 involved bivariate analyses to establish the
relationship between the different independent variables
HIV 
TESTING & 
RANDOM-
IZATION 
TOARM 1 
OR ARM 2
ARM 1
EXTENDEDCOUNSELLING
ARM 2
STANDARD 
COUNSELING
TIME IN MONTHS
3 5 1
PRIMARY 
OUTCOME:
UPTAKE OF PRE-
ARV YES/NO?
Figure 1 Description of the trial time line for assessing uptake of pre-ARV care in Iganga district.
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Page 4 of 11and the outcome variable. The risk ratios (RR) compar-
ing uptake of pre-ARV care in intervention arm to the
control arm, were computed as well as their 95% confi-
dence intervals. All variables where the association with
the outcome variable had a p-value less than 0.2 were
considered important for inclusion in the next stage of
analysis. A stratified analysis in which the computed risk
ratios for different levels of each independent variable
were pooled using the Mantel-Haenszel Risk Ratio
( M H R R )w a sa l s op e r f o r m e d .T h eM H R Rw a sp e r -
formed to adjust for differences in risk ratios of uptake
of pre-ARV at different levels of each independent vari-
able. A Mantel-Haenszel procedure is robust and offers
an elementary alternative of computing a common rate
ratio to the earlier used maximum likelihood estimates
[22].
Stage 3 was a multivariable analysis where different
models assessing the independent effect of the interven-
tion on uptake (primary outcome) to pre-ARV care
were examined by controlling for the different potential
confounders. The multivariable analysis started by com-
puting the RR generated by the intervention alone on
uptake of pre-ARV care. Other models were then com-
puted by cumulatively adding each of the independent
variables that had been significant in stage two above
until all the variables had been exhausted. The interven-
tion was considered significant if the (RR) did not
change significantly for the different generated models.
Ethical clearance
This study was approved by the Makerere University
School of Public Health Institutional Review Board (ref
MUSPH 06012009) and the Iganga district authorities.
Before enrolment into the study, the respondents were
informed about the study aims, their discretion to parti-
cipate or withdraw at any time and assured that all
information obtained from them would be kept confi-
dential. The anticipated benefits or risks of the study to
the participants or the community were clearly
explained and all the study participants signed consent
forms before the interviews commenced.
Results
The study participant flow included a total of 400
newly screened PLHIV who were deemed eligible and
enrolled for the study. The 400 participants were ran-
domly assigned with 200 to the intervention arm and
200 to the control arm. In the intervention arm, 135/
200 clients took up and returned for pre-ARV care
and 65/200 did not return for pre-ARV care. In the
control arm, 77/200 clients took up and returned for
pre-ARV care while 123/200 did not return for pre-
ARV care (Figure 2).
The majority of the participants in both arms were
comparable with regard to gender, (p = 0.75), age (p =
0.48), education status (p = 0.83), marriage status (p =
0.90), occupation (p = 0.62), distance of the PLHIV to
the centre (p = 0.56) and number of people living in the
household together with PLHIV (p = 0.23). There were,
however, observed differences between the two arms
with regard to pre-ARV awareness (p = 0.01), religion (p
= 0.02) and marital status (p = 0.02) although on further
analysis these differences did not significantly influence
the effect of the intervention on the outcome (tables 1,
2 and 3) Both the bivariate and multivariable analyses
were conducted using intention-to-treat with a sample
size of 200 participants for the intervention arm and
200 participants for the control arm. In the bivariate
analysis, comparison of the two arms in relation to the
outcome showed that participants in the intervention
a r mw e r em o r el i k e l yt or e t u r nf o rc a r ec o m p a r e dt o
those in the control arm with an overall percentage of
38.5% and 67.5% for the control and intervention arms
respectively and an unadjusted RR of 1.8 (95% CI: 1.4-
2.1) (table 2). Thus participants in the intervention arm
were 80% more likely to take up pre-ARV care com-
pared to those in the control arm.
The effect of the intervention remained significant after
adjusting for the combined effect of each of the indepen-
dent variables in stratified analysis with a MHRR of pre-
ARV uptake in intervention arm compared to the control
arm ranging from 1.6 to 1.8. Specifically, the MHRRs and
their 95% CIs shown by the independent variables were as
follows: recruitment health centre (Busesa) 1.8 (95% CI
1.4-2.1), sex (male) 1.7 (95% CI 1.4-2.1), age group (18-24
yrs) 1.8 (95% CI 1.4-2.2), education (low education) 1.8
(95% CI 1.4-2.2), marital status (unmarried) 1.8 (95% CI
1.4-2.1), marriage status (monogamous) 1.8 (95% CI 1.4-
2.3), occupation (subsistence farmer) 1.8 (95% CI 1.4-2.1),
religion (Christians) 1.7 (95% CI 1.4-2.1) and pre-ARV
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Not back for care 
(65) 
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Figure 2 Consort participant flow diagram from enrolment to
analysis.
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Page 5 of 11awareness (aware) 1.6 (95% CI 1.3-2.0) (table 2). A test of
homogeneity of the combined MHRR showed no signifi-
cant difference among the strata. The result re-affirms the
significant effect of extended counselling on uptake of pre-
ARV care.
All models generated in the multivariable analysis to
control for potential confounders did not significantly
change the adjusted risk ratio or the 95% confidence
interval imposed by the intervention alone on the out-
come RR 1.8 (1.4-2.1) (table 3)
All participants in both arms were well informed about
HIV transmission, prevention and AIDS defining symp-
toms. The results also show that counseling was a major
reason for participants in the intervention arm to come
back for care (91.6%) compared to (8.4%) in the control
arm (Figure 3). In addition, the majority of clients in the
intervention arm (64.5%) of those who came back for
pre-ARV care had disclosed their HIV status to their
next of kin compared to (34.5%) in the control arm.
Discussion
We show that low-cost extended counseling carried out
by low-level health staff with basic training in counsel-
ing skills complimented with monthly visits to newly
screened PLHIV by community support agents, may
considerably enhance uptake of pre-ARV care. The
study also shows that the majority of clients in the inter-
vention arm had also reportedly disclosed their HIV
Table 1 Description of background characteristicsto test if there were any significant differences between the control
and intervention arms in Iganga district (N = 400).
Characteristic Control
(n = 200) Number (%)
Intervention
(n = 200)
Number (%)
Chi-square/t value (P-value)
Centre
Centre 1 (Busesa) 50 (25.0) 50 (25.0)
Centre 2 (Iganga) 100 (50.0) 100 (50.0)
Centre 3 (Kiyunga) 50 (25.0) 50 (25.0) 0.000 (1.00)
Sex
Male 73 (36.5)’ 70 (35.0)
Female 127 (63.5) 130 (65.0) 0.098 (0.75)
Age (years)
18-24 39 (19.5) 29 (14.5)
25-34 57 (28.5) 68 (34.0)
35-44 58 (29.0) 56 (28.0)
45-70 46 (23.0) 47 (23.5) 2.480 (0.48)
Education
Low education 130 (65.0) 128 (64.0)
Well educated 70(35.0) 72 (36.0) 0.044 (0.83)
Marital status
Unmarried 82 (41.0) 61 (30.5)
Married 118 (59.0) 139 (69.5) 4.799 (0.02)
Marriage status
Monogamous 62 (52.1) 72 (51.8)
Polygamous 56 (47.9) 67 (48.2) 0.014 (0.90)
Occupation
Farmer 134 (67.0) 140 (70.0)
Trader/business 48 (24.0) 40 (20.0)
Salary/wage earner 18 (9.0) 20 (10.0) 0.964 (0.62)
Distance to unit (mean) 21.0 (SD = 19.6) 22.0 (SD = 21.1) 0.590 (0.56)
Household size (mean, SD) 6.1 (SD = 3.8) 6.7 (SD = 5.6) 1.200 (0.23)
Religion
Christians 117 (58.5) 140 (70.0)
Muslims 83 (41.5) 60 (30.0) 5.757 (0.02)
Pre-ARV awareness
Aware 56 (28.0) 81 (40.5)
Not aware 144 (72.0) 119 (59.5) 6.940 (0.01)
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those in the control arm.
Trial limitations
All the staff members who conducted the counseling at
the different centres were from the same units and had
worked together in these units for a long time, thus
complete decontamination between staff was hard to
ensure but genuine efforts were made during pre-trial
training to inform them about the importance of avoid-
ing discussing the intervention.
It was also impossible to entirely ensure that the parti-
cipants did not share information about the trial
b e t w e e nt h e m s e l v e sa l t h o u g ht h i si su n l i k e l yg i v e nt h e
sensitivity of the topic and the high stigma still asso-
ciated with HIV in the community [23].
Since the intervention did not involve following up of
the community support agents,i tw a sa l s od i f f i c u l tt o
ascertain the quality and quantity of counseling they
provided to the participants during follow up visits in
their homes. It is equally hard to ascertain whether it
was the initial post-test counseling provided by the staff
at the unit in the intervention arm, and/or the follow up
counseling provided by the community support agents
that encouraged participants to come back for pre-ARV
care. Unpackaging the intervention could thus be a sub-
ject for further research.
Interpretation and generalizability
Appropriate randomization of participants was done and
the association between the intervention and the out-
come variable should not have been affected by
Table 2 A percentage comparison of uptake of pre-ARV care in the control and intervention arm stratified for
different categories of the baseline characteristics in Iganga district (reference = control arm)
Variable Control
(N = 200)
Intervention
(N = 200)
p-value ratio Crude risk (95% CI) (MH risk ratios)
Recruitment Centre
Centre 1 (Busesa) 36.0 68.0 0.003 1.9 (1.3-2.9) 1.8 (1.4-2.1)
Centre 2 (Iganga) 39.0 68.0 <0.001 1.7 (1.3-2.3)
Centre3 (Kiyunga) 40.0 66.0 0.013 1.7 (1.1-2.5)
Sex
Male 30.1 64.3 <0.001 2.1 (1.4-3.2) 1.7 (1.4-2.1)
Female 43.3 69.2 <0.001 1.6 (1.3-2.0)
Age group
18-24 41.0 65.5 0.050 1.5 (1.1-2.5) 1.8 (1.4-2.2)
25-34 35.1 64.7 0.002 1.8 (1.2-2.7)
35-44 44.8 71.4 0.006 1.6 (1.2-2.2)
45-70 32.6 68.1 0.002 2.0 (1.3-3.3)
Education
Low education 40.0 69.5 <0.001 1.7 (1.4-2.2) 1.8 (1.4-2.2)
High education 35.7 63.8 0.001 1.8 (1.3-2.6)
Marital status
Unmarried 39.0 68.5 <0.001 1.8 (1.3-2.4) 1.8 (1.4-2.1)
Married 38.1 66.9 <0.001 1.8 (1.4-2.3)
Marriage status
Monogamous 35.5 65.3 0.001 1.8 (1.3-2.7) 1.8 (1.4-2.3)
Polygamous 39.0 68.9 <0.001 1.8 (1.3-2.4)
Occupation
Farmer 40.3 65.0 <0.001 1.6 (1.3-2.1) 1.8 (1.4-2.1)
Trader 39.6 72.5 0.003 1.8 (1.2-2.7)
Salary earner 22.2 75.0 0.008 3.4 (1.4-8.3)
Religion
Christians 43.6 75.0 <0.001 1.7 (1.4-2.2) 1.7 (1.4-2.1)
Muslims 31.3 50.0 0.024 1.6 (1.1-2.4)
Pre-ARV awareness
Aware 60.7 86.4 0.002 1.4 (1.1-1.8) 1.6 (1.3-2.0)
Not aware 29.9 54.6 <0.001 1.8 (1.1-1.8)
Overall analysis 38.5 67.5 0.001 1.8 (1.4-2.1)
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ance (table 1). Participants in the intervention arm were
1.8 times more likely to take-up pre-ARV care com-
pared to those in the control arm regardless of differ-
ences in baseline characteristics. The multivariable
analysis showed that the risk ratios generated by the
intervention remained similar and statistically significant
across different models adjusted for confounding. Our
interpretation is thus that t h eh i g hu p t a k eo fp r e - A R V
care in the intervention arm could be explained by the
more adequate counseling offered by staff who had
trained in basic counseling skills. This finding is also
supported by other studies where appropriate counseling
has been found to be vital for health seeking behavior of
PLHIV [4,24-29].
The HIV/AIDS community support agents that
offered further counseling through home visits, encoura-
ging participants to go the nearest health centre for pre-
ARV care also acted as primary care linkages between
the participants and the health care system. The impor-
tance of primary linkages as a tool for improving health
seeking behavior and access to comprehensive HIV care
has also previously been outlined by other studies in
resource-poor settings [30-34].
From a secondary prevention perspective, it is impor-
tant to note that all participants in both arms were
knowledgeable about the modes of HIV transmission,
prevention and HIV defining symptoms. This could pos-
s i b l yb ea t t r i b u t e dt ot h eU g a n d ag o v e r n m e n t ’sm u l t i -
sectoral open policy response to the HIV epidemic,
which, since the 1980s, has increased HIV awareness
among the population [13,35-39].
More participants in the intervention arm who came
back for care had reportedly disclosed their sero-status
to their next of kin compared to participants in the con-
trol arm. This could be explained by the adequacy of
counseling provided in the intervention arm. The rela-
tionship between adequate counseling and HIV status
disclosure has also been demonstrated previously
[2,8,40-51].
Conclusions
The trial demonstrates that if newly screened PLHIV
receive specialized counseling by staff who have received
low-cost training in basic counseling skills, combined
Table 3 Multivariable analysis to assess the effect of the
intervention (extended counselling) on uptake of pre-
ARV care in Iganga district.
Model/Variable Risk ratio (95% CI) P value
Model 1
Intervention* 1.8 (1.4-2.1) <0.001
Model 2
Intervention* 1.7 (1.4-2.1) <0.001
Sex (female) 1.1 (1.0-1.4)
Model 3
Intervention* 1.7 (1.4-2.1) <0.001
Sex (female) 1.2 (1.0-1.4)
Education(primary +) 0.9 (0.8-1.1)
Model 4
Intervention* 1.7 (1.4-2.1) <0.001
Sex (female) 1.1 (0.9-1.4)
Education (primary +) 0.9 (0.8-1.1)
Age group (18-25 yrs)
25-34 1.0 (0.7-1.2)
35-44 1.1 (0.8-1.4)
45-70 1.0 (0.6-1.3)
Model 5
Intervention* 1.7 (1.4-2.1) <0.001
Sex (female) 1.2 (0.9-1.4)
Education (primary +) 0.9 (0.8-1.1)
Age group (18-25 yrs)
25-34 0.9 (0.7-1.2)
35-44 1.1 (0.8-1.4)
45-70 1.0 (0.8-1.3)
Centre 2 (Iganga hosp) 1.0 (0.8-1.2)
Centre 3 (Kiy HSD) 1.0 (0.8-1.2)
Model 6
Intervention* 1.8 (1.4-2.1) <0.001
Sex (female) 1.1 (0.9-1.4)
Education (primary +) 0.9 (0.8-1.1)
Age group (18-25 yrs)
25-34 0.9 (0.7-1.2)
35-44 1.1 (0.8-1.4)
45-70 1.0 (0.7-1.3)
Marital status (married) 1.0 (0.8-1.2)
Model 7
Intervention* 1.8 (1.4-2.1) <0.001
Sex (female) 1.2 (0.9-1.4)
Education (primary +) 0.9 (0.8-1.1)
Marital status (married) 1.0 (0.8-1.2)
Occupation (trader) 1.1 (0.9-1.3)
Occupation (salaried) 1.1 (0.8-1.2)
Model 8
Intervention* 1.8 (1.4-2.1) <0.001
Sex (female) 1.2 (1.0-1.4)
Education (primary +) 0.9 (0.8-1.1)
Marital status (married) 1.00 (0.8-1.2)
Occupation (trader) 1.1 (0.9-1.3)
Table 3 Multivariable analysis to assess the effect of the
intervention (extended counselling) on uptake of pre-
ARV care in Iganga district. (Continued)
Occupation (salaried) 1.1 (0.8-1.4)
Centre 2 (iganga hosp) 0.9 (0.8-1.2)
Centre 3 (Kiy HSD) 0.9 (0.7-1.2)
*Significant at 5% level
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Page 8 of 11with home visits by community support agents, they are
up to 80% more likely to take up pre-ARV care. The
trial further indicates that extended counseling may also
help clients overcome or reprioritize among other bar-
riers to comprehensive HIV care in resource-poor set-
tings such as high transport costs, as well as enhance
social support by encouraging status disclosure. Com-
munity support agents may supplement the efforts of
already overloaded staff at ART clinics and make the
health system more efficient. The findings of the trial
may therefore form a foundation for low cost measures
needed to increase uptake of HIV care and subsequent
follow-up of PLHIV as a cornerstone for retention of
PLHIV under comprehensive HIV care in resource poor
settings.
The cost in terms of the training in basic counseling
skills was only 20 US dollars per staff, a sum that should
be comparable in other rural contexts in sub-Saharan
Africa. In similar settings that are able to mobilize
volunteer community support agents, a similar interven-
tion would be feasible. The authorities would, however,
need to address other important system deficiencies
such as stock-outs of HIV testing kits and cotrimoxa-
zole, poor staff attitudes towards pre-ARV care and staff
confidentiality, that are common in similar settings
[17,52].
The trial findings could be applicable to other Ugan-
dan rural districts and other areas in sub-Saharan Africa
with similar health system and community settings.
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